Changes in John Cunningham virus index in Multiple Sclerosis patients treated with different disease-modifying therapies.
Sign Up to like & getrecommendations! Published in 2021 at "Current neuropharmacology"
DOI: 10.2174/1570159x19666211111123202
Abstract: BACKGROUND Progressive Multifocal Leukoencephalopathy (PML) is an opportunistic infection caused by John Cunningham virus (JCV) reactivation, potentially associated to natalizumab (NTZ) treatment for Multiple Sclerosis (MS). The anti-JCV antibodies titre (JCV index) increases during NTZ… read more here.
Keywords: jcv index; disease modifying; cunningham virus; john cunningham ... See more keywords